Ravi Pottathil


Ravi Pottathil, Ph.D.

“Being passionate about making the world a better place by leveraging modern scientific methods to harness the magic of nature.”


I serve as CEO of AccuDx, Inc., a pharmaceutical diagnostics company. I founded AccuDx, Inc. in 1996. I have served as Section Manager of Retroviruses (focus on HIV and HCV) and Tumor markers and PCR diagnostics of Hoffman La Roche from 1985 to 1992. I Co-founded Specialty Biosystems, Inc., I have advised the World Health Organization’s Sexually Transmitted Diseases and Global Vaccination Program. I served with Dr. Robert Huebner of the NIH in immunology and virology at The Jackson Laboratory, and with Drs. David Lang and Wolfgang Joklik at Duke University on interferons, anti-tumor RNAs and antigenic suppression of tumorigenic retroviruses. I serve as a Director of OncQuest, Inc., GeneQuest, Inc., Specialty Laboratories Asia in Singapore and Specialty Ranbaxy in India.

I served as Member of Scientific Advisory Board of Shrink Nanotechnologies, Inc.  I served as a Member of the Scientific Advisory Board of Aethlon Medical Inc. (Formerly, Bishop Equities Inc.,). I have held many Academic positions including: Assistant Professor at the University of Maryland School of Medicine; Associate Professor at the City of Hope Medical Center in Duarte, California where he published extensively with Dr. Pedro Cuatrecasas (one of developers of affinity chromatography); and Adjunct Professor in Cellular and Molecular Biology at Down State Medical Center and Rutgers University. As a Virologist and Molecular Biologist, I has over 42 refereed publications to my credit.

I received a BS from the University of Kerala, India; an MS and PhD from the Cancer Research Institute, University of Bombay; and a Postdoctoral Fellowship at the Jackson Laboratory and Duke University.